Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. (Q51355256)

4 April 2018

title

Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. (English)

1 reference

4 April 2018

0 references

1 reference

Xin Mao

1

1 reference

4 April 2018

Xiaoyun Pan

2

1 reference

4 April 2018

Song Zhao

3

1 reference

4 April 2018

Xiaochun Peng

4

1 reference

4 April 2018

Tao Cheng

5

1 reference

4 April 2018

Xianlong Zhang

6

1 reference

4 April 2018

publication date

1 August 2012

1 reference

4 April 2018

published in

Inflammation

1 reference

4 April 2018

volume

35

1 reference

4 April 2018

issue

4

1 reference

4 April 2018

page(s)

1378-1391

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s10753-012-9451-8

exact match

0 references

cites work

The role of macrophages in osteolysis of total joint replacement

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Particle bioreactivity and wear-mediated osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Role of RANKL in bone diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Distinct molecular mechanism for initiating TRAF6 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

The proteasome: a new target for novel drug therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Posttranslational quality control: folding, refolding, and degrading proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Bortezomib inhibits human osteoclastogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Inflammatory responses to orthopaedic biomaterials in the murine air pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Macrophage depletion diminishes implant-wear-induced inflammatory osteolysis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

The central role of wear debris in periprosthetic osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

RANK/RANKL: regulators of immune responses and bone physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9451-8

Blockade of vascular endothelial growth factor activity suppresses wear debris-induced inflammatory osteolysis

21 January 2018

1 reference

12 December 2020

Therapeutic potential of the proteasome inhibitor Bortezomib on titanium particle-induced inflammation in a murine model

1 reference

12 December 2020

Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse

1 reference

12 December 2020

Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses

1 reference

12 December 2020

Pharmacologic modulation of periprosthetic osteolysis.

1 reference

12 December 2020

Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement

1 reference

12 December 2020

A study of tissue interface membranes from revision accord knee arthroplasty: the role of T lymphocytes

1 reference

12 December 2020

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

1 reference

12 December 2020

Vascular endothelial growth factor gene silencing suppresses wear debris-induced inflammation

1 reference

12 December 2020

10.1007/S10753-012-9451-8

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

22391745

1 reference

4 April 2018